Teva Pharmaceutical Industries (TEVA) Net Margin (QoQ) (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) Net Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,320.00 |
| Mar 31, 2026 | -68.00 |
| Dec 31, 2025 | 33.00 |
| Sep 30, 2025 | 291.00 |
| Jun 30, 2025 | 107.00 |
| Mar 31, 2025 | 1,514.00 |
| Dec 31, 2024 | -41.00 |
| Sep 30, 2024 | 1,197.00 |
| Jun 30, 2024 | -3,463.00 |
| Mar 31, 2024 | 5,389.00 |
| Dec 31, 2023 | -4,227.00 |
| Sep 30, 2023 | 2,536.00 |
| Jun 30, 2023 | -1,648.00 |
| Mar 31, 2023 | 2,744.00 |
| Dec 31, 2022 | -3,613.00 |
| Sep 30, 2022 | 912.00 |
| Jun 30, 2022 | 1,923.00 |
| Mar 31, 2022 | -2,289.00 |
| Dec 31, 2021 | -1,156.00 |
| Sep 30, 2021 | 250.00 |